In addition it addresses the FDA’s communications with the applicant, the retention of records that assistance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer possession of the SE report back to a fresh applicant and electronic submission in the SE report and amen